LATEST NEWS;”VeriChip shares jump after H1N1 patent license win to develop implantable virus detection systems in humans
Published on 09-21-2009 Email To Friend Print Version
Shares of VeriChip Corp (CHIP.O) tripled after the company said it had been granted an exclusive license to two patents, which will help it to develop implantable virus detection systems in humans.
The patents, held by VeriChip partner Receptors LLC, relate to biosensors that can detect the H1N1 and other viruses, and biological threats such as methicillin-resistant Staphylococcus aureus, VeriChip said in a statement. Continue reading